BENIGN NEOPLASM OF PROSTATE

BENIGN NEOPLASM OF PROSTATE was reported 44 times

BENIGN NEOPLASM OF PROSTATE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-17A Antagonist [EPC] 5 0.0001
1 Cholinesterase Inhibitor [EPC] 1 0.0001
2 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
3 Fluoroquinolone Antibacterial [EPC] 5 0.0000
4 Provitamin D2 Compound [EPC] 1 0.0000
5 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
6 Phosphodiesterase 5 Inhibitor [EPC] 3 0.0000
7 Angiotensin Converting Enzyme Inhibitor [EPC] 3 0.0000
8 Insulin [EPC] 1 0.0000
9 Interleukin-23 Antagonist [EPC] 2 0.0000
10 Integrin Receptor Antagonist [EPC] 1 0.0000
11 Nitrate Vasodilator [EPC] 1 0.0000
12 5-alpha Reductase Inhibitor [EPC] 1 0.0000
13 Interleukin-12 Antagonist [EPC] 1 0.0000
14 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
15 Sulfonylurea [EPC] 1 0.0000
16 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
17 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
18 alpha-Adrenergic Blocker [EPC] 1 0.0000
19 Benzodiazepine [EPC] 4 0.0000
20 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
21 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
22 Platelet Aggregation Inhibitor [EPC] 3 0.0000
23 Tumor Necrosis Factor Blocker [EPC] 5 0.0000
24 Endothelin Receptor Antagonist [EPC] 1 0.0000
25 Thiazide Diuretic [EPC] 1 0.0000
26 Insulin Analog [EPC] 2 0.0000
27 beta-Adrenergic Blocker [EPC] 1 0.0000
28 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
29 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
30 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
31 Loop Diuretic [EPC] 1 0.0000
32 Thalidomide Analog [EPC] 1 0.0000
33 Corticosteroid [EPC] 2 0.0000